3 Penny Stocks on Reddit For Your Watchlist in September
If you’ve invested in penny stocks in the past six months, you’ve likely seen the phenomenon with retail traders on Reddit. During that time, Reddit has become a hub for those who trade penny stocks and blue chips to come together and discuss the market. And this has led to groups of traders investing in small-caps with either high short interest, or a large backing on social media. The result of this has become penny stocks that shoot up in the double or even triple-digit percentage points in only a short time frame.
[Read More] Hot Penny Stocks To Watch Under $1 Right Now
So, while it is extremely difficult to find these stocks before they rise in value, it is not impossible. But, it’s worth noting that penny stocks on Reddit tend to be some of the most volatile stocks out there. And as a result, investors should have a thorough understanding of their own tolerance for risk. So, with this in mind, let’s take a look at three penny stocks on Reddit to watch right now.
3 Reddit Penny Stocks to Watch in September 2021
- Atossa Therapeutics Inc. (NASDAQ: ATOS)
- Seelos Therapeutics Inc. (NASDAQ: SEEL)
- Genius Brands International Inc. (NASDAQ: GNUS)
Atossa Therapeutics Inc. (NASDAQ: ATOS)
Atossa Therapeutics Inc. is a biotech company that has been on many investors’ radars for quite some time. In the past six months and YTD periods, shares of ATOS stock have shot up by over 30% and 245% respectively. These are sizable gains that should be kept in mind. For some context, Atossa is currently developing AT-301, which is a drug candidate for patients diagnosed with COVID-19.
In addition to this, it is developing AT-H201, which is for improving lung function in COVID patients. Companies developing products related to COVID-19 have caught a lot of attention understandably over the past year and a half. Separate from its COVID developments, Atossa is developing medicines for treating cancer. Its lead product is Endoxifen, which is in Phase II clinical trials to treat and prevent breast cancer.
At the start of September, the company received approval from the Swedish Ethics Review Authority to start a Phase 2 clinical study of oral Endoxifen. The purpose of the clinical study is to reduce mammographic breast density in Swedish patients. This condition affects more than 10 million women in the United States and many more around the world.
“With this ethics approval and the previously reported regulatory approval to conduct the clinical study, we plan to start enrolling participants in fourth quarter 2021. We are excited to be working with Dr. Per Hall, a world leader in the field of breast density reduction, once again with our Endoxifen program.”
CEO and Chairman of Atossa, Steven Quay
Now it will be interesting to see what happens with this trial and Endoxifen in the future. For now, is ATOS a contender for your penny stock…